File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Clinical significance of angiogenesis in hepatocellular carcinoma

TitleClinical significance of angiogenesis in hepatocellular carcinoma
Authors
KeywordsAngiogenesis
Hepatocellular carcinoma
Vascular endothelial growth factor
Issue Date2003
PublisherWorld Scientific Publishing Co Pte Ltd. The Journal's web site is located at http://www.worldscinet.com/cr/cr.shtml
Citation
Cancer Reviews: Asia-Pacific, 2003, v. 1 n. 2, p. 167-178 How to Cite?
AbstractHepatocellular carcinoma (HCC) is a hypervascular tumor characterized by neovascularization. Angiogenesis plays an important role in the growth and progression of HCC. Recent studies have indicated that assessment of angiogenic activity in HCC can provide prognostic information independent of conventional clinicopathological factors. Animal studies have demonstrated the efficacy of antiangiogenic agents in suppressing hepatocarcinogenesis and growth of HCC. Early clinical trials on the use of antiangiogenic agents in HCC have already been initiated. This article reviews the available literature on angiogenesis in HCC and discusses its potential clinical significance in the management of HCC. Read More: http://www.worldscientific.com/doi/abs/10.1142/S0219836303000256
Persistent Identifierhttp://hdl.handle.net/10722/84164
ISSN

 

DC FieldValueLanguage
dc.contributor.authorPoon, RTPen_HK
dc.date.accessioned2010-09-06T08:49:43Z-
dc.date.available2010-09-06T08:49:43Z-
dc.date.issued2003en_HK
dc.identifier.citationCancer Reviews: Asia-Pacific, 2003, v. 1 n. 2, p. 167-178en_HK
dc.identifier.issn0219-8363en_HK
dc.identifier.urihttp://hdl.handle.net/10722/84164-
dc.description.abstractHepatocellular carcinoma (HCC) is a hypervascular tumor characterized by neovascularization. Angiogenesis plays an important role in the growth and progression of HCC. Recent studies have indicated that assessment of angiogenic activity in HCC can provide prognostic information independent of conventional clinicopathological factors. Animal studies have demonstrated the efficacy of antiangiogenic agents in suppressing hepatocarcinogenesis and growth of HCC. Early clinical trials on the use of antiangiogenic agents in HCC have already been initiated. This article reviews the available literature on angiogenesis in HCC and discusses its potential clinical significance in the management of HCC. Read More: http://www.worldscientific.com/doi/abs/10.1142/S0219836303000256-
dc.languageengen_HK
dc.publisherWorld Scientific Publishing Co Pte Ltd. The Journal's web site is located at http://www.worldscinet.com/cr/cr.shtmlen_HK
dc.relation.ispartofCancer Reviews: Asia-Pacificen_HK
dc.rightsCancer Reviews: Asia-Pacific. Copyright © World Scientific Publishing Co Pte Ltd.-
dc.subjectAngiogenesis-
dc.subjectHepatocellular carcinoma-
dc.subjectVascular endothelial growth factor-
dc.titleClinical significance of angiogenesis in hepatocellular carcinomaen_HK
dc.typeArticleen_HK
dc.identifier.emailPoon, RTP: poontp@hkucc.hku.hken_HK
dc.identifier.authorityPoon, RTP=rp00446en_HK
dc.identifier.doi10.1142/S0219836303000256-
dc.identifier.hkuros87854en_HK
dc.identifier.volume1-
dc.identifier.issue2-
dc.identifier.spage167-
dc.identifier.epage178-
dc.publisher.placeSingapore-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats